BRIGHT MINDS BIOSCIENCES INC. Share Issue Related Cost
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Share Issue Related Cost of CAD 26.98 thousand for the 12-month period ending 2023-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ShareIssueRelatedCost · last filed 2024-12-31
| Period end | Share Issue Related Cost 12 month |
|---|---|
| 2023-09-30 | 26.98K CAD 20-F · filed 2024-12-31 |
| 2022-09-30 | 260.65K CAD 20-F · filed 2024-12-31 |
| 2021-09-30 | 290.31K CAD 20-F · filed 2023-12-29 |
| 2020-09-30 | 5.24K CAD 20-F · filed 2022-12-29 |